Drug Research
WuXi Advanced Therapies Announces Licensing Agreement with Janssen
WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, announced a licensing agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson (“Janssen”). Under this agreement, WuXi ATU will license to...
Press Releases
Mayne Pharma Announces Sale of Metrics Contract Services for US$475 Million
Mayne Pharma Group Limited announced that it has entered into an agreement with Catalent, Inc., the global leader in enabling biopharma, cell, gene, and consumer health partners to optimise development, launch, and supply of better patient treatments across multiple...
Press Releases
The New Nebula® Multimode Reader from Lonza Streamlines Quantitative Endotoxin Detection
Lonza has launched the Nebula® Multimode Reader, the first multimode reader qualified for use with Lonza’s turbidimetric, chromogenic and recombinant endotoxin detection methods. Users can now directly compare results from absorbance-based and fluorescence-based endotoxin assays in one reader, reducing...
Press Releases
Frontier Biotechnologies Announces Positive Phase 1 Results of its First Coronavirus Main Protease (MPRO) Small Molecule Inhibitor
Frontier Biotechnologies, a biopharmaceutical company focused on the discovery, development and dissemination of innovative medicines that improve patient health, announced positive results from the Phase 1 clinical trial of its drug candidate, FB2001 – a small molecule inhibitor of...
Press Releases
Airnov to exhibit range of healthcare packaging solutions to Indian market at Innopack Pharma Confex-South
Airnov Healthcare Packaging, a global leader in controlled atmosphere packaging, will be showcasing its large portfolio of solutions available to customers in India at the upcoming Innopack Pharma Confex-South, due to be held in the city of Hyderabad on...
Press Releases
Baxter Pharmaceuticals India celebrates five years of operations in Ahmedabad, India
Baxter Pharmaceuticals India Private Limited (BPIPL), Ahmedabad based generic injectables manufacturing facility has successfully completed five years of its robust presence in India. The company acquired a well-known generic injectables company for $625 million in 2017. The Baxter Ahmedabad...
Drug Research
AstraZeneca’s Enhertu wins keenly-anticipated U.S. breast cancer nod
AstraZeneca (AZN.L) and Daiichi Sankyo (4568.T) on Friday secured U.S. approval that broadens the use of their therapy Enhertu, for patients with breast cancer, and paves the way for billions in sales.
This is the first-ever U.S. Food and Drug Administration (FDA) approval for...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read